483 Amneal Pharmaceuticals Nov 2013

483 Amneal Pharmaceuticals Nov 2013

Michael Klapal FDA$595.00 - Available Now

FDA investigators audited the Amneal Pharmaceuticals - Paterson, NJ, United States facility and issued inspectional observation (via FDA 483) on 13 Nov 2013.

Product details

  • Category: Human Drugs
  • Inspection end: 13 Nov 2013
  • Location: Paterson, United States
  • FEI: 3003792057
Add To Cart